Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

PD-MitoQUANT

PD-MitoQUANT holds Final Project Meeting in Copenhagen

7th July 2022

Time has certainly flown! With the PD-MitoQUANT project formally ending in July 2022, project partners

Missed the Parkinson’s Research in Ireland event? Videos are now available!

28th April 2022

The third annual Parkinson’s Research in Ireland talk series was held on March 31st and

Neuronet convenes 8th meeting of its Scientific Coordination Board

1st April 20221st April 2022

On 30 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened

Neuronet publishes series of project introduction videos during Brain Awareness Week

20th April 202214th March 2022

The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines

Parkinson’s Research in Ireland 2022 event announced

22nd March 20227th March 2022
PD-MITOQUANT logo Newsletter Mitochondrial dysfunction Parkinson

The popular online event series to share information about Parkinson’s Research in Ireland continues in

PD-MitoQUANT team assembles for plenary meeting hosted by ICM

20th April 20229th February 2022
PDMQ-Paris-meeting-ICR-1-scaled-e1644333393894

Some members of the PD-MitoQUANT team were hosted by Dr Olga Corti and the team

Neuronet convenes annual event on European research collaboration in Alzheimer’s disease & beyond

22nd December 2021

Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together

Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”

16th November 20218th November 2021
IMI nd projects social media campaign

The Neuronet project is setting up an efficient platform to boost collaboration across research projects

Spotlight on early-career researchers: a Neuronet interview with Hannah Scheiblich

7th March 202213th October 2021
Spotlight on early-career researchers: a Neuronet interview with Hannah Scheiblich

In this Neuronet interview, we speak with Hannah Scheiblich. Hannah works as a postdoctoral researcher on

Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

23rd September 2021
PD-MITOQUANT logo Newsletter Mitochondrial dysfunction Parkinson

The latest Innovative Medicines Initiative (IMI) funded PD-MitoQUANT publication shows that Microglia form F-actin dependent

Post navigation
Older posts
Page1 Page2 Page3 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2023 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT